Synthesis, purification, and tumor cell uptake of67Ga-deferoxamine-folate, a potential radiopharmaceutical for tumor imaging

Bioconjugate Chemistry

Volumn 7, Issue 1, 1996, Pages 56-62

  Wang, Susan ^a   Lee, Robert J ^a   Mathias, Carla J ^b   Green, Mark A ^b   Low, Philip S ^a  

^a PURDUE UNIVERSITY   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOSYNTHESIS; CELL CULTURE; CELLS; CHELATION; CHROMATOGRAPHY; DIAGNOSIS; ISOMERS; LIGANDS; ORGANIC ACIDS; TUMORS;

AMIDE BOND; CELL UPTAKE; CHELATING AGENT; DEFEROXAMINE; FOLATE RECEPTOR; FOLATES; FOLIC ACIDS; PURIFICATION CELL; TUMOR IMAGING; TUMOUR CELLS;

AMINES; TUMORS;

EID: 0030019317     PISSN: 10431802     EISSN: None     Source Type: Journal    
DOI: 10.1021/bc9500709     Document Type: Article

References (49)

1. Antony, A. C., Kane, M. A., Portillo. R. M., Elwood, P. C ., and Kolbouse, J. F. (1985) Study of the role of a particulate folate-binding protein in the uptake of 5-methyltetrahydrofolate. J. Biol. Chem. 260, 14911-14917.
2. Bates, R. G., Vega, C. A ., and White, D. R. (1978) Standards for pH measurements in isotonic saline media of ionic strength I=0.16. Anal. Chem. 50, 1295-1300.
3. Campbell, I. G., Jones, T. A., Foulkes, W. D ., and Trowsdale, J. (1991) Folate-binding protein is a marker for ovarian cancer. Cancer Res. 51, 5329-5338.
4. Coney, L. R., Tomassetti, A., Carayannopoulos, L., Frasca, V., Kamen, B. A., Colnaghi, M. I ., and Zurawski, V. R., Jr. (1991) Cloning of a tumor-associated antigen: MOvl8 and MOvl9 antibodies recognize a folate-binding protein. Cancer Res. 51, 6125-6132.
5. Elwood, P. C. (1989) Molecular cloning and characterisation of the human folate-binding protein cDNA from placenta, and malignant tissue culture (KB) cells. J. Biol. Chem. 264, 14893-14901.
6. Fan, J. G., Pope, L. E., Vitols, K. S ., and Huennekens, F. M. (1991) Affinity labeling of folate transport proteins with the N-hydroysuccinimide ester of the γ-isomer of fluoresceinmethotrexate. Biochemistry 30, 4573-80.
7. Fischman, A. J., Babich, J. W ., and Strauss, H. W. (1993) A ticket to ride: peptide radiopharmaceuticals. J. Nucl. Med. 34, 2253-2263.
8. Franklin, W. A., Waintrub, M., Edwards, D., Christensen, K., Prendegrast, P., Woods, J., Bunn, P. A ., and Kolhouse, J. F. (1994) New anti-lung-cancer antibody cluster 12 reacts with human folate receptors present on adenocarcinoma. Int. J. Cancer 8 (Suppl.), 89-95.
9. Fritzberg, A. R., Berninger, R. W., Hadley, S. W ., and Wester, D. W. (1988) Approaches to radiolabeling of antibodies for diagnosis and therapy of cancer. Pharm. Res. 5, 325-334.
10. Front, D ., and Israel, O. (1995) The role of Ga-67 scintigraphy in evaluating the results of therapy of lymphoma patients. Semin. Nucl. Med. 25, 60-71.
11. Furukawa, T., Fujibayashi, Y., Fukunaga, M., Saga, T., Endo, K ., and Yokoyama, A. (1991) An approach for immunoradiometric assay with metallic radionuclides: gallium-67 - deferroxamine - dialdehyde starch - IgG. J. Nucl. Med. 32, 825-829.
12. Garin-Chesa, P., Campbell, I., Saigo, P., Lewis, J., Old, L ., and Rettig, W. (1993) Trophoblast and ovarian cancer antigen LK26. Sensitivity and specificity in immunopathology and molecular identification as a folate-binding protein. Am. J. Pathol. 142, 557-567.
13. Green, M. A. (1993) Metal radionuclides in diagnostic imaging by positron emission tomography (PET). Adv. Metals Med. 1, 75-114.
14. Green, M. A ., and Welch, M. J. (1989) Gallium radiopharma-ceutical chemistry. Int. J. Rad. Appl. Instrum. 16, 435-448.
15. Griffiths, G. L., Goldenberg, D. M., Jones, A. L ., and Hansen, H. J. (1992) Radiolabeling of monoclonal antibodies and fragments with technetium and rhenium. Bioconjugate Chem. 3, 91-99.
16. Harris, W. R ., and Pecoraro, V. L. (1983) Thermodynamic binding constants for gallium transferrin. Biochemistry 22, 292-299.
17. Hayes, R. L. (1978) The medical use of gallium radionuclides: a brief history with some comments. Semin. Nucl. Med. 8, 183-192.
18. Holm, J., Hansen, S. I., Hoier-Madsen, M., Sondergaard, K ., and Bzorek, M. (1994) Folate receptor of human mammary adenocarcinoma. APMIS 102, 413-419.
19. Kamen, B. A ., and Capdevila, A. (1986) Receptor-mediated folate accumulation is regulated by the cellular folate content. Proc. Natl. Acad. Sci. U.S.A. 83, 5983-5987.
20. Kamen, B. A., Wang, M. T., Streckfuss, A. J., Peryea, X ., and Andersen, R. G. W. (1988) Delivery of folates to the cytoplasm of MA104 cells is mediated by a surface membrane receptor that recycles. J. Biol Chem. 263, 13602-13609.
21. Kane, M. A ., and Waxman, S. (1989) Role of folate binding proteins in folate metabolism. Lab. Invest. 60, 737-746.
22. Lacey, S. W., Sanders, J. M., Rothberg, K. G., Anderson, R. G. W ., and Kamen, B. A. (1989) Complementary DNA for the folate binding protein correctly predicts anchoring to the membrane by glycosyl-phosphatidylinositol. J. Clin. Invest. 84, 715-720.
23. Lamki, L, M. (1995) Tissue characterization in nuclear oncology: its time has come. J. Nucl. Med. 36, 207-210.
24. Leamon, C. P ., and Low, P. S. (1991) Delivery of macromolecules into living cells: a method that exploits folate receptor endocytosis. Proc. Natl. Acad. Sci. U.SA. 88, 5572-5576.
25. Leamon, C. P ., and Low, P. S. (1992) Cytotoxicity of momordin-folate conjugates in cultured human cells. J. Biol. Chem. 267, 24966-24971.
26. Leamon, C. P ., and Low, P. S. (1993) Membrane folate-binding proteins are responsible for folate-protein conjugate endocytous into cultured cells. Biochem. J. 291, 855-860.
27. Leamon, C. P., Pastan, I ., and Low, P. S. (1993) Cytotoxicity of folate-pseudomonaa exotoxin conjugates toward tumor cells. J. Biol. Chem. 268, 24847-24854.
28. Lee, R J ., and Low, P. S. (1994) Delivery of liposomes into cultured KB cells via folate receptor-mediated endocytosis. J. Biol. Chem. 269, 3198-3204.
29. Lentle, B. C. (1986) Tumor detection with radiolabeled agents. Current Applications in Radiopharmacology (M. W. Billinghurst, Ed.) pp 48-61, Pergamon Press, Canada.
30. Levy, C. C ., and Goldman, P. (1967) The enzymatic hydrolysis of methotrexate and folic acid. J. Biol. Chem. 242, 2933-2938.
31. Luhrs, C. A., Raskin, C. A., Durbin, R., Wu, B., Sadasivan, E., McAllister, W ., and Rothenberg, S. P. (1992) Transfection of a glycosylated phosphatidylinositol-anchored folate-binding protein complementary DNA provides cells with the ability to survive in low folate medium. J. Clin, Invest. 90, 840-847.
32. Matsue, H., Rothberg, K. G., Takashima, A., Kamen, B. A., Anderson, R. G. W ., and Lacey, S. W. (1992) Folate receptor allows cells to grow in low concentrations of 5-methyltetrahydrofolate. Proc. Natl. Acad. Sci. U.S.A. 89, 6006-6009.
33. I. J. Biol. Chem. 246, 7207-7213.
34. McHugh, M ., and Cheng, Y. C. (1979) Demonstration of a high affinity folate binder in human cell membranes and its characterization in cultured human KB cells. J. Biol. Chem, 254, 11312-11318.
35. Presant, C. A., Proffitt, R. T., Turner, A. F., Williams, L. E., Winsor, D., Werner J, L., Kennedy, P., Wiseman, C., Gala, K., McKenna, R J., Smith, J, D., Bouzaglou, S. A., Callahan, R A., Baldeschwieler, J ., and Crossley, R. J. (1988) Successful imaging of human cancer with indium-111-labeled phospholipid vesicles. Cancer 62, 905-911.
36. Rettig, W., Garin-Chesa, P., Beresford, H., Oettgen, H., Melamed, M ., and Old, L. (1988) Cell-surface glycoproteins of human sarcomas: differential expression in normal and malignant tissues and cultured cells. Proc. Natl. Acad. Sci. U.S.A. 85 3110-3114.
37. Richardson, D ., and Baker, E. (1992) Two mechanisms of iron uptake from transferrin by melanoma cells. The effect of desferrioxamine and ferric ammonium citrate. J. Biol. Chem. 267, 13972-13979.
38. Ross, J. F., Chaudhuri, P. K ., and Ratnam, M. (1994) Differential regulation of folate receptor isoforms in normal and malignant tissues in vivo and in established cell lines. Physiologic and clinical implications. Cancer 73, 2432-2443.
39. Serafini, A. N., Ed. (1993) Monoclonal antibody imaging: crossing the research/clinical barrier Semin. Nucl. Med. 23(2), 87-179.
40. Smith-Jones, P. M., Stolz. B., Bruns, C., Albert, R., Reist. H. W., Fridrich, R ., and Macke, H. R. (1994) Gallium-67/gallium-68-[DFO]-octreotide-a potential radiopharmaceutical for PET imaging of somatostatin receptor-positive tumors: synthesis and radiolabeling in vitro and preliminary in vivo studies. J. Nucl. Med. 35, 317-325.
41. Sohn. M. H., Jones. B. J., Whiting, J. H., Jr., Datz, F. L., Lynch, R E ., and Morton, K. A. (1993) Distribution of gallium-67 in normal and hypotransferrinemic tumor-bearing mice. j. Nucl. Med. 34, 2135-2143.
42. van Leeuwen-Stok, A. E., Drager. A. M., Schuurhuis, G. J., Platier, A. W., Teule, G J ., and Huijgens, P. C. (1993) Gallium 67 in the human lymphoid cell line U-715: uptake, cytotoxicity and intracellular localization. Int. J. Radiat. Biol. 64, 749-759.
43. Verma, D. R. (1992) Gallium-labeled deferoxamine-galactosylneoglycoalbumin: a radiopharmaceutical for regional measurement of hepatic receptor biochemistry. J. Nucl. Med. 33, 1160-1166.
44. Wagner, S. J ., and Welch, W. J. (1979) Gallium-68 labeling of albumin and albumin microspheres. J. Nucl. Med. 20, 428-433.
45. Wang, S., Lee, R J., Cauchon, G., Gorenstein, D. G ., and Low, P. S. (1995) Delivery of antisense oligonucleotides against the human epidermal growth factor receptor into cultured KB cells with liposomes conjugated to folate via polyethyleneglycol. Proc. Natl. Acad. Sci. U.S.A. 92. 3318-3322.
46. Weiner, R E., Thakur, M. L., Goodman, M ., and Hoffer, P. B. (1979) Relative stability of In-111 and Ga-67 desferrioxamine and human transferrin complexes. Radiopharmaceuticals II, pp 331-340, Society of Nuclear Medicine, New York.
47. Weitman, S. D., Lark, R. H., Coney, L. R., Fort, D. W., Frasca, V., Zurawski, V.R, Jr ., and Kamen, B. A. (1992) Distribution of the folate receptor (GP38) in normal and malignant cell lines and tissues. Cancer Res. 52, 3396-3401.
48. Wilbur, D. S. (1992) Radiohalogenation of proteins: an overview of radionuclides, labeling methods, and reagents for conjugate labeling. Bioconjugate Chem. 3, 433-470.
49. Yokoyama, A., Ohmomo, Y., Horiuchi, K., Saji, H., Tanaka, H., Yamamoto, K ., and Ishii, Y. (1982) Deferoxamine, a promising bifunctional chelating agent for labeling proteins with gallium: Ga-67-DF-HSA: concise communication. J. Nucl. Med. 23, 909-914,